Herti 440 mg is an injectable formulation of Trastuzumab, a targeted monoclonal antibody primarily used to treat HER2-positive breast and metastatic gastric cancers. It works by b…
Herti 440 mg is an injectable formulation of Trastuzumab, a targeted monoclonal antibody primarily used to treat HER2-positive breast and metastatic gastric cancers. It works by binding to HER2 proteins, thereby inhibiting cancer cell growth and promoting immune-mediated cell destruction.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Dosage Form Injection
Treatment Breast Cancer, Gastric Cancer, Metastatic Cancer, Esophageal Cancer, HER2-Positive Cancers
Packaging Type Vial
Brand Herti
Manufacturer Hetero Healthcare Limited
Strength 440 mg
Brand Name Herti
Manufactured By Hetro Healthcare
Country of Origin Made in India
Pack Size 1 injection in 1 vial
Minimum order quantity: 50 Piece
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
